Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel.

ABSTRACT: The first local spread of COVID-19 in Israel was detected in March 2020. Due to the diversity in clinical presentations of COVID-19, diagnosis by RT-PCR alone might miss patients with mild or no symptoms. Serology testing may better evaluate the actual magnitude of the spread of infection in the population. This is the first nationwide seroprevalence study conducted in Israel. It is one of the most widespread to be conducted thus far, and the largest per-country population size. The survey was conducted between June 28 and September 14, 2020 and included 54,357 patients who arrived at the Health Maintenance Organizations to undergo a blood test for any reason. A patient was considered seropositive after two consecutive positive results with two different kits (Abbott and DiaSorin).The over

SUBMITTER: Reicher S 

PROVIDER: S-EPMC8059683 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature